T 2214/17 (PCSK9 E670G mutants/KYMAB) of 15.03.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T221417.20210315
- Date of decision
- 15 March 2021
- Case number
- T 2214/17
- Online on
- 28 January 2022
- Petition for review of
- -
- Application number
- 14185297.0
- IPC class
- C07K 16/40
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Antibodies for use in treating conditions related to specific PCSK9 variants in specific patient populations
- Applicant name
- Kymab Limited
- Opponent name
- -
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56Rules of procedure of the Boards of Appeal 2020 Art 013(1)Rules of procedure of the Boards of Appeal Art 12(4)
- Keywords
- Late-filed request - admitted (yes)
Amendment to appeal case - suitability of amendment to resolve issues raised (yes)
Inventive step - obvious alternative - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
- The appeal is dismissed.